Systemic sclerosis (scleroderma)

Injury	Disease	Nutrition	Poison

Symptoms	Surgery	Test	Special Topic

Raynaud's phenomenon

Systemic sclerosis (scleroderma)

Alternative Names:

CREST syndrome; Progressive systemic sclerosis; Scleroderma
Treatment:

text continues below

Medicines that treat inflammation and pain include aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or corticosteroids. Other treatments are directed at specific manifestations of systemic sclerosis: for example, antacids or intestinal motility drugs for heartburn and related symptoms, medications that increase blood flow for Raynaud's phenomenon, and blood pressure medications (particularly ACE inhibitors) for high blood pressure or kidney problems.

Treatment usually includes a combination of physical therapy and skin and joint protection techniques (for example, avoiding cold in the case of Raynaud's phenomenon).

Support Groups:

See scleroderma - support group.

Expectations (prognosis):

In the majority of those affected, the disease is progressive. In some, remission occurs with a slow progression. People who only have skin involvement have a better prognosis (probable outcome). Death may occur from gastrointestinal, cardiac, kidney, or pulmonary (lung) involvement.

Complications:

Cardiac failure
Renal failure
Pulmonary fibrosis
Malabsorption (inadequate absorption of nutrients from the intestinal tract)

Calling your health care provider:

Call for an appointment with your health care provider if symptoms of this disorder are present, or if you have scleroderma and symptoms become worse, or if new symptoms develop.